1
|
American Diabetes Association, . Diagnosis
and Classification of Diabetes Mellitus. Diabetes Care. 32 (Suppl
1):S62–S67. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Li L, Pan Z, Yang S, Shan W and Yang Y:
Identification of key gene pathways and coexpression networks of
islets in human type 2 diabetes. Diabetes Metab Syndr Obes.
11:553–563. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ling Q, Xu X, Wang B, Li L and Zheng S:
The origin of new-onset diabetes after liver transplantation:
Liver, Islets, or Gut? Transplantation. 100:808–813. 2016.
View Article : Google Scholar : PubMed/NCBI
|
4
|
DeFronzo RA: Pathogenesis of type 2
diabetes mellitus. Med Clin North Am. 88:787–835. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Schattenberg JM and Schuchmann M: Diabetes
and apoptosis: Liver. Apoptosis. 14:1459–1471. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Michael MD, Kulkarni RN, Postic C, Previs
SF, Shulman GI, Magnuson MA and Kahn CR: Loss of insulin signaling
in hepatocytes leads to severe insulin resistance and progressive
hepatic dysfunction. Mol Cell. 6:87–97. 2000. View Article : Google Scholar : PubMed/NCBI
|
7
|
Shimomura I, Matsuda M, Hammer RE,
Bashmakov Y, Brown MS and Goldstein JL: Decreased IRS-2 and
increased SREBP-1c lead to mixed insulin resistance and sensitivity
in livers of lipodystrophic and ob/ob Mice. Mol Cell. 6:77–86.
2000. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lewis GF, Carpentier A, Adeli K and Giacca
A: Disordered fat storage and mobilization in the pathogenesis of
insulin resistance and type 2 diabetes. Endocr Rev. 23:201–229.
2002. View Article : Google Scholar : PubMed/NCBI
|
9
|
McGarry JD: Banting lecture 2001
dysregulation of fatty acid metabolism in the etiology of type 2
diabetes. Diabetes. 51:7–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
10
|
Postic C and Girard J: Contribution of de
novo fatty acid synthesis to hepatic steatosis and insulin
resistance: Lessons from genetically engineered mice. J Clin
Invest. 118:829–838. 2008. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Honda M, Asonuma K, Hayashida S, Suda H,
Ohya Y, Lee KJ, Yamamoto H, Takeichi T and Inomata Y: Incidence and
risk factors for new-onset diabetes in living-donor liver
transplant recipients. Clin Transplant. 27:426–435. 2013.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41((Databaseissue)):
D991–D995. 2013.PubMed/NCBI
|
13
|
Gaulton KJ, Ferreira T, Lee Y, Raimondo A,
Mägi R, Reschen ME, Mahajan A, Locke A, Rayner NW, Robertson N, et
al: Genetic fine mapping and genomic annotation defines causal
mechanisms at type 2 diabetes susceptibility loci. Nat Genet.
47:1415–1425. 2015. View
Article : Google Scholar : PubMed/NCBI
|
14
|
Lawlor N, Khetan S, Ucar D and Stitzel ML:
Genomics of Islet (Dys)function and Type 2 Diabetes. Trends Genet.
33:244–255. 2017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Stitzel ML, Sethupathy P, Pearson DS,
Chines PS, Song L, Erdos MR, Welch R, Parker SC, Boyle AP, Scott
LJ, et al: Global epigenomic analysis of primary human pancreatic
islets provides insights into type 2 diabetes susceptibility loci.
Cell Metab. 12:443–455. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhang F, Xu X, Zhang Y, Zhou B, He Z and
Zhai Q: Gene expression profile analysis of type 2 diabetic mouse
liver. PLoS One. 8:e577662013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Barrett T and Edgar R: Gene expression
omnibus: Microarray data storage, submission, retrieval, and
analysis. Methods Enzymo. 411:352–369. 2006. View Article : Google Scholar
|
18
|
Misu H, Takamura T, Takayama H, Hayashi H,
Matsuzawa-Nagata N, Kurita S, Ishikura K, Ando H, Takeshita Y, Ota
T, et al: A liver-derived secretory protein, selenoprotein P,
causes insulin resistance. Cell Metab. 12:483–495. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Szklarczyk D, Franceschini A, Kuhn M,
Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork
P, et al: The STRING database in 2011: Functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids
Res. 39((Database)): 561–568. 2011. View Article : Google Scholar
|
21
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Rana R, Surapureddi S, Kam W, Ferguson S
and Goldstein JA: Med25 is required for RNA polymerase II
recruitment to specific promoters, thus regulating xenobiotic and
lipid metabolism in human liver. Mol Cell Biol. 31:466–481. 2011.
View Article : Google Scholar : PubMed/NCBI
|
23
|
DeAngelis AM, Heinrich G, Dai T, Bowman
TA, Patel PR, Lee SJ, Hong EG, Jung DY, Assmann A, Kulkarni RN, et
al: Carcinoembryonic antigen-related cell adhesion molecule 1: A
link between insulin and lipid metabolism. Diabetes. 57:2296–2303.
2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Mohamed J, Nazratun Nafizah AH, Zariyantey
AH and Budin SB: Mechanisms of diabetes-induced liver damage: The
role of oxidative stress and inflammation. Sultan Qaboos Univ Med
J. 16:e132–e141. 2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Sadi G, Pektaş MB, Koca HB, Tosun M and
Koca T: Resveratrol improves hepatic insulin signaling and reduces
the inflammatory response in streptozotocin-induced diabetes. Gene.
570:213–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
26
|
van der Kallen CJ, van Greevenbroek MM,
Stehouwer CD and Schalkwijk CG: Endoplasmic reticulum
stress-induced apoptosis in the development of diabetes: Is there a
role for adipose tissue and liver? Apoptosis. 14:1424–1434. 2009.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Rosen OM: After insulin binds. Science.
237:1452–1458. 1987. View Article : Google Scholar : PubMed/NCBI
|
28
|
Scheffzek K and Ahmadian MR: GTPase
activating proteins: Structural and functional insights 18 years
after discovery. Cell Mol Life Sci. 62:3014–3038. 2005. View Article : Google Scholar : PubMed/NCBI
|
29
|
Wang H, Zhang Q, Chai Y, Liu Y, Li F, Wang
B, Zhu C, Cui J, Qu H and Zhu M: 1,25(OH)2D3 downregulates the
Toll-like receptor 4-mediated inflammatory pathway and ameliorates
liver injury in diabetic rats. J Endocrinol Invest. 38:1083–1091.
2015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Huang S, Rutkowsky JM, Snodgrass RG,
Ono-Moore KD, Schneider DA, Newman JW, Adams SH and Hwang DH:
Saturated fatty acids activate TLR-mediated proinflammatory
signaling pathways. J Lipid Res. 53:2002–2013. 2012. View Article : Google Scholar : PubMed/NCBI
|
31
|
Ye L, Kleiner S, Wu J, Sah R, Gupta RK,
Banks AS, Cohen P, Khandekar MJ, Boström P, Mepani RJ, et al: TRPV4
is a regulator of adipose oxidative metabolism, inflammation, and
energy homeostasis. Cell. 151:96–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
32
|
Zeisel MB, Dhawan P and Baumert TF: Tight
junction proteins in gastrointestinal and liver disease. Gut.
68:547–561. 2018. View Article : Google Scholar
|
33
|
Krischer J, Gilbert A, Gorden P and
Carpentier JL: Endocytosis is inhibited in hepatocytes from
diabetic rats. Diabetes. 42:1303–1309. 1993. View Article : Google Scholar : PubMed/NCBI
|
34
|
Yang M, He RL, Benovic JL and Ye RD:
beta-Arrestin1 interacts with the Gprotein subunits beta1gamma2 and
promotes beta1gamma2-dependent Akt signalling for NF-kappaB
activation. Biochem J. 417:287–296. 2009. View Article : Google Scholar : PubMed/NCBI
|
35
|
Russell DW, Schneider WJ, Yamamoto T,
Luskey KL, Brown MS and Goldstein JL: Domain map of the LDL
receptor: Sequence homology with the epidermal growth factor
precursor. Cell. 37:577–585. 1984. View Article : Google Scholar : PubMed/NCBI
|
36
|
Zhang L, Fairall L, Goult BT, Calkin AC,
Hong C, Millard CJ, Tontonoz P and Schwabe JW: The IDOL-UBE2D
complex mediates sterol-dependent degradation of the LDL receptor.
Genes Dev. 25:1262–1274. 2011. View Article : Google Scholar : PubMed/NCBI
|
37
|
Bordone L and Guarente L: Calorie
restriction, SIRT1 and metabolism: Understanding longevity. Nat Rev
Mol Cell Biol. 6:298–305. 2005. View
Article : Google Scholar : PubMed/NCBI
|
38
|
Brooks CL and Gu W: How does SIRT1 affect
metabolism, senescence and cancer? Nat Rev Cancer. 9:123–128. 2009.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Chang HC and Guarente L: SIRT1 and other
sirtuins in metabolism. Trends Endocrinol Metab. 25:138–145. 2014.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Scott RA, Lagou V, Welch RP, Wheeler E,
Montasser ME, Luan J, Mägi R, Strawbridge RJ, Rehnberg E,
Gustafsson S, et al: Large-scale association analyses identify new
loci influencing glycemic traits and provide insight into the
underlying biological pathways. Nat Genet. 44:991–1005. 2012.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Huyghe JR, Jackson AU, Fogarty MP,
Buchkovich ML, Stančáková A, Stringham HM, Sim X, Yang L,
Fuchsberger C, Cederberg H, et al: Exome array analysis identifies
new loci and low-frequency variants influencing insulin processing
and secretion. Nat Genet. 45:197–201. 2013. View Article : Google Scholar : PubMed/NCBI
|
42
|
Hara K, Fujita H, Johnson TA, Yamauchi T,
Yasuda K, Horikoshi M, Peng C, Hu C, Ma RC, Imamura M, et al:
Genome-wide association study identifies three novel loci for type
2 diabetes. Hum Mol Genet. 23:239–246. 2014. View Article : Google Scholar : PubMed/NCBI
|
43
|
Higurashi M, Ohya Y, Joh K, Muraguchi M,
Nishimura M, Terawaki H, Yagui K, Hashimoto N, Saito Y and Yamada
K: Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients
with Type 2 diabetic nephropathy. J Diabetes Complications 2009.
23:178–184. 2009. View Article : Google Scholar
|
44
|
Nawaz MI, Van Raemdonck K, Mohammad G,
Kangave D, Van Damme J, Abu El-Asrar AM and Struyf S: Autocrine
CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells
and are enhanced in diabetic retinopathy. Exp Eye Res. 109:67–76.
2013. View Article : Google Scholar : PubMed/NCBI
|
45
|
Zychowska M, Rojewska E, Pilat D and Mika
J: The role of some chemokines from the CXC subfamily in a mouse
model of diabetic neuropathy. J Diabetes Res. 2015:7501822015.
View Article : Google Scholar : PubMed/NCBI
|
46
|
Yu J, Wu H, Liu ZY, Zhu Q, Shan C and
Zhang KQ: Advanced glycation end products induce the apoptosis of
and inflammation in mouse podocytes through CXCL9-mediated
JAK2/STAT3 pathway activation. Int J Mol Med. 40:1185–1193. 2017.
View Article : Google Scholar : PubMed/NCBI
|
47
|
Melander O, Maisel AS, Almgren P, Manjer
J, Belting M, Hedblad B, Engström G, Kilger U, Nilsson P, Bergmann
A and Orho-Melander M: Plasma proneurotensin and incidence of
diabetes, cardiovascular disease, breast cancer, and mortality.
JAMA. 308:1469–1475. 2012. View Article : Google Scholar : PubMed/NCBI
|
48
|
Li J, Song J, Zaytseva YY, Liu Y, Rychahou
P, Jiang K, Starr ME, Kim JT, Harris JW, Yiannikouris FB, et al: An
obligatory role for neurotensin in high fat diet-induced obesity.
Nature. 533:411–415. 2016. View Article : Google Scholar : PubMed/NCBI
|
49
|
Léon C, Freund M, Latchoumanin O, Farret
A, Petit P, Cazenave JP and Gachet C: The P2Y1 receptor is involved
in the maintenance of glucose homeostasis and in insulin secretion
in mice. Purinergic Signal. 2005:145–151. 2005. View Article : Google Scholar
|
50
|
Breuker C, Amouzou C, Fabre O, Lambert K,
Seyer P, Bourret A, Salehzada T, Mercier J, Sultan A and Bisbal C:
Decreased RNF41 expression leads to insulin resistance in skeletal
muscle of obese women. Metabolism. 83:81–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
51
|
Pearson G and Soleimanpour SA: A
ubiquitin-dependent mitophagy complex maintains mitochondrial
function and insulin secretion in beta cells. Autophagy.
14:1160–1161. 2018. View Article : Google Scholar : PubMed/NCBI
|